Abstract
BackgroundThe prognosis for pancreatic ductal adenocarcinoma (PDAC) remains dismal due to limited options for surgical resection, as well as minimally effective treatments for patients presenting with advanced disease.1 PDAC is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
